Search results
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 7 hours agovaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and older,...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 3 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 5 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 4 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThat way, you can have some time between shots before it’s time to get your fall flu shot and an...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 16 hours agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 24 hours agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
Fact Check: Trump Supposedly Awarded Dr. Anthony Fauci a Presidential Commendation. We...
Snopes via Yahoo News· 4 days agoPresident Donald Trump awarded Dr. Anthony Fauci with a presidential commendation for his...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 1 day agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved...